CME Group Inc. $CME Stock: Voya Investment Management LLC Boosts Holdings

CME Group logo with Finance background
Image from MarketBeat Media, LLC.

Key Points

  • Voya Investment Management increased its CME Group holdings by 515.8% in the third quarter, adding 641,679 shares to reach 766,090 shares valued at about $200.5 million. Institutional investors and hedge funds own 87.75% of the stock.
  • Analyst views are mixed: CME has a consensus Hold rating and a $314.44 average price target, despite several firms raising their targets.
  • CME beat quarterly earnings and revenue estimates, reporting EPS of $3.02 and revenue up 10.6% year over year. It also declared a $1.30 quarterly dividend per share.
  • Five stocks we like better than CME Group.

Voya Investment Management LLC grew its holdings in CME Group Inc. (NASDAQ:CME - Free Report) by 515.8% in the 3rd quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 766,090 shares of the financial services provider's stock after purchasing an additional 641,679 shares during the quarter. Voya Investment Management LLC owned 0.21% of CME Group worth $200,522,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. BlackRock Inc. acquired a new stake in CME Group during the 2nd quarter worth $6,749,965,000. Bank of America Corp DE increased its stake in shares of CME Group by 39.1% during the first quarter. Bank of America Corp DE now owns 4,019,944 shares of the financial services provider's stock worth $1,187,290,000 after acquiring an additional 1,130,587 shares during the period. Bank of New York Mellon Corp acquired a new stake in shares of CME Group in the 2nd quarter valued at approximately $867,313,000. Alphabet Inc. acquired a new position in shares of CME Group during the 2nd quarter worth $769,376,000. Finally, Mitsubishi UFJ Asset Management Co. Ltd. acquired a new stake in shares of CME Group during the 2nd quarter valued at approximately $629,771,000. 87.75% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

CME has been the topic of a number of recent research reports. Piper Sandler reaffirmed an "overweight" rating and issued a $330.00 target price (up from $295.00) on shares of CME Group in a research note on Thursday, October 22nd. Morgan Stanley lifted their price target on shares of CME Group from $337.00 to $359.00 and gave the company an "overweight" rating in a report on Thursday, October 22nd. TD Cowen boosted their target price on CME Group from $292.00 to $300.00 and gave the stock a "buy" rating in a report on Monday, October 5th. UBS Group raised their target price on CME Group from $270.00 to $310.00 and gave the company a "neutral" rating in a report on Thursday, October 22nd. Finally, Bank of America raised their target price on CME Group from $226.00 to $230.00 and gave the company an "underperform" rating in a research note on Thursday, July 23rd. Ten analysts have rated the stock with a Buy rating, six have assigned a Hold rating and two have given a Sell rating to the stock. Based on data from MarketBeat.com, CME Group currently has a consensus rating of "Hold" and a consensus price target of $314.44.

View Our Latest Report on CME

Insider Transactions at CME Group

In related news, insider Sunil Cutinho sold 5,000 shares of the company's stock in a transaction on Tuesday, October 27th. The shares were sold at an average price of $298.70, for a total transaction of $1,493,500.00. Following the completion of the transaction, the insider directly owned 20,037 shares in the company, valued at $5,985,051.90. This represents a 19.97% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, insider Julie Winkler sold 10,079 shares of CME Group stock in a transaction that occurred on Monday, November 2nd. The stock was sold at an average price of $305.15, for a total value of $3,075,606.85. Following the sale, the insider directly owned 21,482 shares in the company, valued at $6,555,232.30. The trade was a 31.93% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Over the last three months, insiders have sold 33,511 shares of company stock worth $9,714,580. Insiders own 0.30% of the company's stock.

CME Group Price Performance

Shares of NASDAQ:CME opened at $311.56 on Wednesday. The stock has a fifty day moving average of $287.44 and a 200-day moving average of $281.82. The company has a market capitalization of $111.52 billion, a PE ratio of 25.56, a price-to-earnings-growth ratio of 3.90 and a beta of 0.15. CME Group Inc. has a one year low of $218.31 and a one year high of $329.16. The company has a debt-to-equity ratio of 0.13, a quick ratio of 1.02 and a current ratio of 1.02.

CME Group (NASDAQ:CME - Get Free Report) last issued its earnings results on Wednesday, October 21st. The financial services provider reported $3.02 EPS for the quarter, topping the consensus estimate of $2.99 by $0.03. CME Group had a return on equity of 16.23% and a net margin of 63.33%. The business had revenue of $1.74 billion during the quarter, compared to analysts' expectations of $1.71 billion. During the same quarter last year, the firm posted $2.68 earnings per share. CME Group's revenue was up 10.6% compared to the same quarter last year. As a group, equities analysts anticipate that CME Group Inc. will post 12.35 EPS for the current fiscal year.

CME Group Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Wednesday, December 30th. Shareholders of record on Friday, December 11th will be issued a dividend of $1.30 per share. This represents a $5.20 dividend on an annualized basis and a yield of 1.7%. The ex-dividend date is Friday, December 11th. CME Group's dividend payout ratio is 42.66%.

About CME Group

(Free Report)

CME Group operates a global marketplace for derivatives and other financial products. Through its exchanges—CME, CBOT, NYMEX and COMEX—it offers futures and options contracts tied to interest rates, equity indexes, foreign exchange, energy, agricultural products and metals. The company also provides clearing and settlement services, market data and related products. Its electronic trading platform, CME Globex, supports access to its markets by participants around the world, alongside its open-outcry and privately negotiated trading services.

Further Reading

Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc. (NASDAQ:CME - Free Report).

Institutional Ownership by Quarter for CME Group (NASDAQ:CME)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in CME Group Right Now?

Before you consider CME Group, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and CME Group wasn't on the list.

While CME Group currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

10 Best Stocks to Own in Fall 2026 Cover

AI spending is reshaping the market, and the opportunity extends far beyond the biggest chipmakers. Discover 10 stocks set to benefit from powerful trends in AI infrastructure, cloud computing, energy, capital returns, and consumer growth this fall.

Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines